feed,title,long_url,short_url
SeekingAlpha,Chemocentryx shares plunge 47% as FDA report identifies concerns with vasculitis candidate,https://seekingalpha.com/news/3690237,
SeekingAlpha,"Morgan Stanley sees Roku's dominance already priced in, in competitive market; shares slip 6%",https://seekingalpha.com/news/3690245,
